Comparative efficacy of once-weekly semaglutide versus SGLT-2 inhibitors in patients inadequately controlled with one to two oral antidiabetic drugs: a systematic literature review and network meta-analysis

Comparative efficacy of once-weekly semaglutide versus SGLT-2 inhibitors in patients inadequately controlled with one to two oral antidiabetic drugs: a systematic literature review and network meta-analysis

Objective To determine the comparative efficacy of once-weekly semaglutide relative to sodium-glucose cotransporter 2 inhibitors (SGLT-2is) licensed in Europe and North America among patients with type 2 diabetes (T2D) inadequately controlled with 1–2 oral antidiabetics (OADs), using a network meta-...

Full description

Saved in:

Bibliographic Details
Main Authors:	Steve Kanters, Lars Wilkinson, Hrvoje Vrazic, Rohini Sharma, Sandra Lopes, Evan Popoff, Eric Druyts
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2019-07-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/9/7/e023458.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands
by: Barnaby Hunt, et al.
Published: (2019-05-01)

Effects of Once-Weekly Semaglutide on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 Trial
by: Katherine R. Tuttle, et al.
Published: (2024-07-01)

Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses
by: Ildiko Lingvay, et al.
Published: (2020-11-01)

Weight Loss Effects of Once-Weekly Semaglutide 2.4 mg in Adults with and Without Type 2 Diabetes: A Systematic Review and Meta-Analysis
by: Boram Hong, et al.
Published: (2025-07-01)

Efficacy and safety of once-weekly semaglutide monotherapy in a young subject with Prader-Willi syndrome, obesity, and type 2 diabetes: a case report
by: Elisa Dinoi, et al.
Published: (2025-02-01)

Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study
by: Tomohiko Kimura, et al.
Published: (2024-01-01)

Mitochondrial insights on antidiabetic therapies: Differential impacts of SGLT2i, GLP-1, and insulin
by: Yu-Hsiang Lin, et al.
Published: (2025-02-01)

Nonsurgical Corrective Union of Osteoporotic Vertebral Fracture with Once-Weekly Teriparatide
by: Naohisa Miyakoshi, et al.
Published: (2015-01-01)

Semaglutide and the Retina
by: Zachary T. Bloomgarden
Published: (2025-04-01)

Once‐Weekly Insulin Versus Once‐Daily Insulin for Type 1 Diabetes Treatment: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
by: Obieda Altobaishat, et al.
Published: (2025-05-01)

Network Meta-Analysis of Once Weekly Selinexor-Bortezomib-Dexamethasone in Previously Treated Multiple Myeloma
by: Michael Dolph, et al.
Published: (2021-08-01)

Semaglutide therapy and iatrogenic thyrotoxicosis
by: Maxim John Levy Barnett, et al.
Published: (2025-07-01)

Diffuse Podocytopathy Associated With Semaglutide
by: Rose Mary Attieh, et al.
Published: (2024-05-01)

Spotlight on the Mechanism of Action of Semaglutide
by: Ilias Papakonstantinou, et al.
Published: (2024-12-01)

Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing
by: Erica Nishimura, et al.
Published: (2021-03-01)

Commentary on “Assessment of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer’s disease: A population-based study”
by: Feng Chen, et al.
Published: (2025-05-01)

Inadequate Lymph Node Yield: An Inadequate Indication for Adjuvant Chemotherapy in Stage II Colon Cancer
by: Alan Zambeli-Ljepović, MD, MHS, et al.
Published: (2023-12-01)

The World As It Once Was
by: Kees Rookmaaker
Published: (2021-10-01)

Granuloma annulare after starting semaglutide
by: Tajena Jones, BS, et al.
Published: (2025-08-01)

Semaglutide-induced fixed drug eruption
by: Sahithi Talasila, BS, et al.
Published: (2025-02-01)

Contractile Effects of Semaglutide in the Human Atrium
by: Joachim Neumann, et al.
Published: (2024-08-01)

Upadacitinib as monotherapy in patients with rheumatoid arthritis and prior inadequate response to methotrexate: results at 260 weeks from the SELECT-MONOTHERAPY randomised study
by: Josef S Smolen, et al.
Published: (2025-05-01)

Epidemiology of the 2020 pandemic of COVID‐19 in the state of Georgia: Inadequate critical care resources and impact after 7 weeks of community spread
by: Justin Xavier Moore, et al.
Published: (2020-08-01)

Safety considerations of semaglutide in the potential treatment of Alzheimer's disease: A pooled analysis of semaglutide in adults aged ≥ 65 years
by: Marwan Sabbagh, et al.
Published: (2025-04-01)

Effects of once-weekly subcutaneous retatrutide on weight and metabolic markers: A systematic review and meta-analysis of randomized controlled trials
by: Eric Pasqualotto, et al.
Published: (2024-12-01)

A Case of Semaglutide-Induced Skin Burning
by: Maia Stokes, et al.
Published: (2025-03-01)

Once again on globalization
by: Hatibović Džemal
Published: (2002-01-01)

The Once and Future Library
by: Gerry McKiernan
Published: (1996-12-01)

Çeviriyi Eleştirmeden Önce
by: Ülker İnce
Published: (1993-02-01)

Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies
by: Marina V. Shestakova, et al.
Published: (2017-08-01)

Treatment completion and safety profile of once-weekly 3HP regimen for tuberculosis preventive treatment in children and adolescents: a systematic review
by: Sipang Pangprasertkul, et al.
Published: (2025-03-01)

The Cost-Effectiveness of Continuous Erythropoiesis Receptor Activator Once Monthly versus Epoetin Thrice Weekly for Anaemia Management in Chronic Haemodialysis Patients
by: Omar Maoujoud, et al.
Published: (2015-01-01)

Semaglutide and bariatric surgery induce distinct changes in the composition of mouse white adipose tissue
by: Margo P. Emont, et al.
Published: (2025-05-01)

Clinical Holistic Medicine: When Biomedicine is Inadequate
by: Søren Ventegodt, et al.
Published: (2004-01-01)

Semaglutide in MASLD Patients: Improved Survival and Liver Outcomes
by: Mohamad Suki, et al.
Published: (2025-07-01)

Effects of Semaglutide on CKD in Patients With Type 2 Diabetes
by: Sradha S. Kotwal, et al.
Published: (2025-02-01)

Oral semaglutide: the innovation in type 2 diabetes management
by: M. V. Shestakova, et al.
Published: (2021-09-01)

Advocating for The Once and Future Library
by: Daisy D. Singh
Published: (2024-12-01)

Once Again, Nationality and Religion
by: Steven E. Grosby
Published: (2019-09-01)

Continuous Glucose Monitoring and Hypoglycaemia Metrics With Once‐Weekly Basal Insulin Fc Versus Insulin Degludec: A Systematic Review and Meta‐Analysis
by: Saaed Abunada, et al.
Published: (2025-07-01)